Literature DB >> 11991641

Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo.

Dominique Lévesque1, Sanaa Choufani, Jean-Pierre Perreault.   

Abstract

The stability of a trans-acting delta ribozyme was studied under various conditions. Although in vitro (i.e., in the presence of protein extracts) this delta ribozyme appears to be only slightly more stable than a hammerhead ribozyme, in vivo (i.e., after cell transfection) it exhibits an outstanding stability that manifests itself in the calculated half-life of over 100 h regardless of the means of transfection. The P2 stem, which includes both the 5' and 3' ends, is shown to play a critical role in this stability. Direct mutagenesis of the most nuclease susceptible nucleotides failed to generate a more stable ribozyme that retained the same catalytic potential. Clearly, delta ribozyme appears to be well adapted to the human cell environment, and is therefore ideal for the development of a gene-inactivation system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991641      PMCID: PMC1370269          DOI: 10.1017/s1355838202020289

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  31 in total

1.  Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells.

Authors:  Y Kato; T Kuwabara; M Warashina; H Toda; K Taira
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

Review 2.  Regulation of mRNA stability in mammalian cells.

Authors:  J Guhaniyogi; G Brewer
Journal:  Gene       Date:  2001-03-07       Impact factor: 3.688

3.  General acid-base catalysis in the mechanism of a hepatitis delta virus ribozyme.

Authors:  S Nakano; D M Chadalavada; P C Bevilacqua
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

Review 4.  Ribozyme structures and mechanisms.

Authors:  E A Doherty; J A Doudna
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Requirement for canonical base pairing in the short pseudoknot structure of genomic hepatitis delta virus ribozyme.

Authors:  F Nishikawa; S Nishikawa
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

7.  Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.

Authors:  L Cagnon; J J Rossi
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-08

8.  The kinetics and magnesium requirements for the folding of antigenomic delta ribozymes.

Authors:  S Ananvoranich; J P Perreault
Journal:  Biochem Biophys Res Commun       Date:  2000-04-13       Impact factor: 3.575

Review 9.  Ribozyme therapy for HIV infection.

Authors:  J J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2000-10-31       Impact factor: 15.470

10.  Cationic liposome-mediated RNA transfection.

Authors:  R W Malone; P L Felgner; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more
  16 in total

1.  Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.

Authors:  Lucien Junior Bergeron; Jonathan Ouellet; Jean-Pierre Perreault
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

2.  Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes.

Authors:  Karine Fiola; Jean-Pierre Perreault; Benoit Cousineau
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

3.  Functional characterization of the SOFA delta ribozyme.

Authors:  Lucien Junior Bergeron; Cédric Reymond; Jean-Pierre Perreault
Journal:  RNA       Date:  2005-10-26       Impact factor: 4.942

4.  Identification of a peach latent mosaic viroid hairpin able to act as a Dicer-like substrate.

Authors:  Patricia Landry; Jean-Pierre Perreault
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  A Two-Metal-Ion-Mediated Conformational Switching Pathway for HDV Ribozyme Activation.

Authors:  Tai-Sung Lee; Brian K Radak; Michael E Harris; Darrin M York
Journal:  ACS Catal       Date:  2016-02-01       Impact factor: 13.084

6.  Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus.

Authors:  Lucien Junior Bergeron; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

7.  Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme.

Authors:  Patrick Deschênes; Jonathan Ouellet; Jonathan Perreault; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

8.  Potassium ions modulate a G-quadruplex-ribozyme's activity.

Authors:  Jean-Denis Beaudoin; Jean-Pierre Perreault
Journal:  RNA       Date:  2008-05-02       Impact factor: 4.942

9.  Investigating a new generation of ribozymes in order to target HCV.

Authors:  Michel V Lévesque; Dominique Lévesque; Francis P Brière; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  Silencing of SPC2 expression using an engineered delta ribozyme in the mouse betaTC-3 endocrine cell line.

Authors:  François D'Anjou; Lucien Junior Bergeron; Nadia Ben Larbi; Isabelle Fournier; Michel Salzet; Jean-Pierre Perreault; Robert Day
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.